epidemiology of non alcoholic fatty liver disease (NAFLD)
Last reviewed 11/2022
epidemiology
With the rapid rise in sedentary life style, metabolic syndrome and obesity, prevalence of NAFLD amongst the general population has increased considerably.
- worldwide prevalence of NAFLD is thought to be 20% in the general population and up to 70% in patients with type 2 diabetes mellitus (1)
- the community-based Framingham heart study population has reported a prevalence of 17% (19% in men and 15% in women) with the prevalence approaching 90% in patients considering bariatric surgery (2)
- NAFLD is the most common cause of chronically elevated LFTs in the United States in both diabetic and nondiabetic individuals
- with respect to patients with NAFLD, 60-95% are obese, 28-55% have type 2 diabetes, and 20-92% have hyperlipidemia (3)
Prevalence of NAFLD
- increases with age
- is higher in men than in women
- in a study of 26,527 subjects undergoing medical checkups, the prevalence of NAFLD was 31% in men and 16% in women
- in hispanic individuals is significantly higher and in non-hispanic blacks is significantly lower when compared to non-hispanic whites (4).
Prevalence of NAFLD in High Risk Groups
- patients with severe obesity undergoing bariatric surgery
- the prevalence of NAFLD can exceed 90%
- up to 5% of patients may have unsuspected cirrhosis
- type 2 diabetes mellitus patients
- ultrasonographic studies have reported a 69% prevalence of NAFLD in type 2 diabetes patients
- dyslipidemia
- the prevalence of NAFLD was estimated to be 50% in patients attending lipid clinics
Reference:
- (1) Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ. 2014;349:g4596
- (2) Wilkins T et al. Nonalcoholic fatty liver disease: diagnosis and management. Am Fam Physician. 2013;88(1):35-42.
- (3) Harris EH.Elevated Liver Function Tests in Type 2 Diabetes.Clinical Diabetes 2005; 23:115-119
- (4) Chalasani N et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23